ClinicalTrials.gg
RecruitingNCT06859918Updated Mar 13, 2026

Randomized Clinical Trial of TUNE In 3.0: A Social/Emotional Program for Adults With Autism Spectrum Disorder

An interventional study of TUNE In: Training to Understand and Navigate Emotions and Interactions in Autism Spectrum Disorder, Autism and Autistic Disorder, sponsored by University of Pennsylvania. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-13.

Sponsored by University of Pennsylvania · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Mar 2025; still recruiting 1 year 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 773 studies in Autism Spectrum Disorder with a site in United States — 163 open to participants now, 203 under way, 9 of them phase 3. Autism Spectrum Disorder · United States.

Planned enrollment
377th of 658
40 · median 50
Started
2025
with 31 others
No phase
456 of 773
104 open now
Primary completion
2027-12
later than 125 of 201 live
Registered
708th of 773
by date

Among the 773 studies in Autism Spectrum Disorder with a site in United States, this one is the 377th largest by planned enrollment of the 658 interventional ones that give a count, is one of 32 that started in 2025, is one of 456 with no phase, reaches primary completion later than 125 of the 201 other live ones, and was the 708th registered.

Autism Spectrum Disorder

1,733 studies on the registry are indexed under Autism Spectrum Disorder; 503 are open to participants now.

Browse Autism Spectrum Disorder studies →

Open to participants now

163 of the 773 studies in Autism Spectrum Disorder with a site in United States are open now. Recruiting first, the newest first:

158 more — sign in →

All 163 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 351 Autism Spectrum Disorder studies recruiting now, 48 (14%) set no upper age limit and 296 (84%) stop at 75 or younger; 301 take children under 18; 92 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 773 studies in Autism Spectrum Disorder with a site in United States, or all of them as a file.
02

Study summary

The purpose of this study is to test a novel, cognitive behavioral treatment strategy to improve social functioning in adults with autism spectrum disorder.

The treatment, named TUNE In (Training to Understand and Navigate Emotions and Interactions), includes components to address the many behavioral domains involved in social functioning, including social motivation, social anxiety, social cognition, social skills, and generalization of the skills to community settings.

The Investigators will test the efficacy of TUNE In to improve social functioning in adults with autism spectrum disorder (ASD), using a randomized controlled trial using the SRS-2 as the primary outcome measure.

03

Conditions studied

  • Autism Spectrum Disorder
  • Autism
  • Autistic Disorder
  • Asperger Syndrome

Keywords

  • Social Skills
  • Emotion Regulation
  • Autistic Adults
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 18 years of age or older
  • Meet ASD diagnostic criteria supported by an outside diagnostic evaluation and/or by the clinical and developmental information gathered from a phone screen
  • Be willing to complete screening surveys (outcome measures)
  • Social Responsiveness Score, Second Edition, self-report SRS survey score of greater than or equal to 60

Exclusion criteria

Exclusion Criteria:

  • Severe self-injurious or aggressive behaviors; or with suicidal or homicidal ideation or behaviors (e.g. suicide attempt) within the last 6 months
  • Major mood episode (major depressive episode, manic episode), psychotic symptoms, or a psychiatric hospitalization within the last 6 months
  • A history of intellectual disability or low Shipley-2 score
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Other
    Delay Start Group

    The Delay Start Group receives the intervention 1-6 months after the Immediate Start Group.

    Behavioral: TUNE In: Training to Understand and Navigate Emotions and Interactions

  • Experimental
    Immediate Start Group

    The Immediate Start Group receives the intervention as soon as the trial starts.

    Behavioral: TUNE In: Training to Understand and Navigate Emotions and Interactions

Interventions

  • BehavioralTUNE In: Training to Understand and Navigate Emotions and Interactions

    A cognitive behavioral treatment strategy to improve social functioning in adults with autism spectrum disorder. TUNE In includes components to address the many behavioral domains involved in social functioning, including social motivation, social anxiety, social cognition, and social skills.

06

What researchers measure

Primary outcomes

  1. Social Responsiveness Scale (SRS) - Self Report

    A 65 item self-report measure that identifies the presence and severity of social impairment within the autism spectrum.

    Time frame: From enrollment to 6 months follow up

Secondary outcomes

  1. Social Responsiveness Scale (SRS) - Informant Report

    A 65 item measure that identifies the presence and severity of social impairment within the autism spectrum. This is completed by a friend/family member of the participant based on their perceptions of the participants' behavior.

    Time frame: From enrollment to 6 months follow up

  2. CAT-Q - Camouflaging Autistic Traits Questionnaire

    A 25 item measure that assesses the extent to which individuals with autism mask or camouflage their autistic traits in social situations.

    Time frame: From enrollment to 6 months follow up

  3. Five Facet Mindfulness Questionnaire

    A 39-item measure that assesses five aspects of mindfulness: observing, describing, acting with awareness, non-judging, and non-reactivity.

    Time frame: From enrollment to 6 months follow up

  4. Generalized Anxiety Disorder-7

    A 7-item measure that assesses the severity of generalized anxiety disorder symptoms.

    Time frame: From enrollment to 6 months follow up

  5. Glasgow Sensory Questionnaire

    A 42-item measure that assesses sensory sensitivities and differences across multiple sensory modalities.

    Time frame: From enrollment to 6 months follow up

  6. Insomnia Severity Inde

    A 7-item measure that assesses the severity of insomnia symptoms and their impact on daily functioning.

    Time frame: From enrollment to 6 months follow up

  7. Inventory of Socially Supportive Behaviors

    A 40-item measure that assesses the frequency and types of social support individuals receive.

    Time frame: From enrollment to 6 months follow up

  8. Social Network Index

    A 12-item measure that assesses the size, diversity, and level of engagement in an individual's social network.

    Time frame: From enrollment to 6 months follow up

  9. Scales of Psychological Wellbeing

    A 42 item measure that assesses six dimensions of psychological well-being: autonomy, environmental mastery, personal growth, positive relations with others, purpose in life, and self-acceptance.

    Time frame: From enrollment to 6 months follow up

  10. Attunement Quiz

    A 25 item measure that assess attunement: one's ability to perceive, interpret, and respond to one's internal and external environment, in particular the social environment.

    Time frame: From enrollment to 6 months follow up

  11. Liebowitz Social Anxiety Scale - Self-Report

    A 24-item measure that assesses the severity of social anxiety symptoms related to fear and avoidance in social and performance situations.

    Time frame: From enrollment to 6 months follow up

07

Study locations

1 of 1 sites recruiting
  • Brodkin Lab: Perelman School of Medicine, Department of Psychiatry, University of Pennsylvania
    Philadelphia, Pennsylvania 19104, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Data will be available through NIH NDAR registry

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code

Time frame: Deidentified data will be uploaded to NDAR upon completion of the trial

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2025 (actual). Primary completion is estimated for Dec 2027, 33 months after the start.

Of 806 non-industry interventional studies with no phase under Autism Spectrum Disorder, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 48. This study's planned 33 months is above that.

Counting every sponsor, half of 829 studies reached it within 25 months; a quarter within 12 and three quarters within 47.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 27, 2025
First posted
Mar 5, 2025
StartActual
Mar 24, 2025
Primary completionEst.
Dec 2027
CompletionEst.
Dec 2027
Last update
Mar 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06859918
Responsible party
Sponsor
First posted
Mar 5, 2025
Start date
Mar 24, 2025
Primary completion
Dec 2027 (estimated)
Completion
Dec 2027 (estimated)
Last update
Mar 13, 2026

Study contacts

Edward Brodkin, M.D
Contact
ebrodkin@pennmedicine.upenn.edu
215-746-4100
Edward Brodkin, MD
principal investigator · University of Pennsylvania

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion